United States · FDA National Drug Code directory
Cefepime
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 44567-241_d2a51dbe-bcbf-4f4c-9f38-2516649c3b2f
- Product NDC
- 44567-241
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- Cefepime
- Labeler
- WG Critical Care, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20141010
- Source listing expiry
- 20271231
Source-listed ingredients
- CEFEPIME HYDROCHLORIDE — 2 g/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (44567-241-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL · 44567-241-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →